immunomodulating activity
Recently Published Documents


TOTAL DOCUMENTS

157
(FIVE YEARS 13)

H-INDEX

28
(FIVE YEARS 3)

2021 ◽  
Author(s):  
Kari Skjånes ◽  
Reidun Aesoy ◽  
Lars Herfindal ◽  
Hanne Skomedal

2020 ◽  
Vol 12 (5) ◽  
pp. 1104-1107
Author(s):  
Saybel Saybel OL ◽  
Rendyuk Rendyuk TD ◽  
Dargaeva Dargaeva TD ◽  
Nikolaev Nikolaev SM ◽  
Khobrakova Khobrakova VB

Author(s):  
O. Michalak ◽  
P. Krzeczyński ◽  
M. Cieślak ◽  
P. Cmoch ◽  
M. Cybulski ◽  
...  

2020 ◽  
Vol 56 (2) ◽  
pp. 226-232 ◽  
Author(s):  
O. V. Kalmantaeva ◽  
V. V. Firstova ◽  
N. S. Grishchenko ◽  
T. I. Rudnitskaya ◽  
V. D. Potapov ◽  
...  

Molecules ◽  
2019 ◽  
Vol 24 (20) ◽  
pp. 3632 ◽  
Author(s):  
Yuan-Feng Zou ◽  
Yan-Yun Zhang ◽  
Yu-Ping Fu ◽  
Kari Inngjerdingen ◽  
Berit Paulsen ◽  
...  

In this study, an acidic polysaccharide from Codonopsis pilosula Nannf. var. modesta (Nannf.) L. T. Shen (WCP-I) and its main fragment, WCP-Ia, obtained after pectinase digestion, were structurally elucidated and found to consist of a rhamnogalacturonan I (RG-I) region containing both arabinogalactan type I (AG-I) and type II (AG-II) as sidechains. They both expressed immunomodulating activity against Peyer’s patch cells. Endo-1,4-β-galactanase degradation gave a decrease of interleukine 6 (IL-6) production compared with native WCP-I and WCP-Ia, but exo-α-l-arabinofuranosidase digestion showed no changes in activity. This demonstrated that the stimulation activity partly disappeared with removal of β-d-(1→4)-galactan chains, proving that the AG-I side chain plays an important role in immunoregulation activity. WCP-Ia had a better promotion effect than WCP-I in vivo, shown through an increased spleen index, higher concentrations of IL-6, transforming growth factor-β (TGF-β), and tumor necrosis factor-α (TNF-α) in serum, and a slight increment in the secretory immunoglobulin A (sIgA) and CD4+/CD8+ T lymphocyte ratio. These results suggest that β-d-(1→4)-galactan-containing chains in WCP-I play an essential role in the expression of immunomodulating activity. Combining all the results in this and previous studies, the intestinal immune system might be the target site of WCP-Ia.


2019 ◽  
Vol 29 (3) ◽  
pp. 266-276
Author(s):  
Maksim Ostankov ◽  
◽  
Larisa Leonova ◽  
Nikolay Bondarovich ◽  
Lyudmila Ostankova ◽  
...  

2019 ◽  
Vol 2019 (2) ◽  
pp. 37-44
Author(s):  
Александр Санин ◽  
Aleksandr Sanin ◽  
Анна Деева ◽  
Anna Deeva ◽  
Татьяна Кожевникова ◽  
...  

Much controversy exists concerning the problem of immunomodulators (IMD) usage in aviculture. We state that most reasonable way consists in the usage of IMD possessing not only immunomodulating activity, but some additional useful features as well: adjuvant, adaptogenic, anti-inflammatory, and antioxidative activities, stimulation of growth and development, etc. In this review special emphasis is made upon Phosprenyl and Gamavit, IMD which meet all of the above criteria. Moreover, use of these drugs poultry farmers literally begin ab ovo. We analyzed specific features of Phosprenyl and Gamavit usage both in the embryonic and postembryonic periods of broiler chickens breeding. An important advantage of these medicines is that, being classic IMD, they simultaneously possess the ability to enhance embryogenesis, growth and development of chickens, have antioxidant effect, stimulate hematopoiesis. All this makes it possible to widely use these drugs in industrial poultry, ensuring food security of our country.


Sign in / Sign up

Export Citation Format

Share Document